Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 62Recruiting 41Active not recruiting 33Terminated 14Withdrawn 12Unknown 7Not yet recruiting 2Suspended 1Enrolling by invitation 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Clinical Stage I Gastric Cancer AJCC v8 1

Interventions

Cisplatin 9Specimen Handling 7Educational Status 7Standard of Care 6Interviews as Topic 6Drug Therapy 6Carboplatin 6Blood Specimen Collection 6Radiotherapy 5Nivolumab 5Chemoradiotherapy 5Surgical Procedures, Operative 4Paclitaxel 4Oxaliplatin 4Observation 4Lenalidomide 4Fluorouracil 4Dexamethasone 4pembrolizumab 3lenvatinib 3camrelizumab 3Surveys and Questionnaires 3Practice Guidelines as Topic 3Patient Navigation 3Methods 3Magnetic Resonance Spectroscopy 3Magnetic Resonance Imaging 3Gemcitabine 3Fluorodeoxyglucose F18 3Exercise 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Enrolling by invitation × 1,2-diaminocyclohexaneplatinum II citrate × Clear all
NCT07139951 2025-12-31

HORIZON

Mayo Clinic

Phase 2 Enrolling by invitation
16 enrolled
Gastrointestinal

Clinical Stage I Gastric Cancer AJCC v8

Data powered by HemOnc (CC BY 4.0) Colophon âš¡